| Innate and adaptive immune cells in the tumor microenvironment TF Gajewski, H Schreiber, YX Fu Nature immunology 14 (10), 1014-1022, 2013 | 4019 | 2013 |
| Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice L Deng, H Liang, B Burnette, M Beckett, T Darga, RR Weichselbaum, ... The Journal of clinical investigation 124 (2), 687-695, 2014 | 2042 | 2014 |
| STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors L Deng, H Liang, M Xu, X Yang, B Burnette, A Arina, XD Li, H Mauceri, ... Immunity 41 (5), 843-852, 2014 | 1848 | 2014 |
| Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment Y Lee, SL Auh, Y Wang, B Burnette, Y Wang, Y Meng, M Beckett, ... Blood, The Journal of the American Society of Hematology 114 (3), 589-595, 2009 | 1440 | 2009 |
| Radiotherapy and immunotherapy: a beneficial liaison? RR Weichselbaum, H Liang, L Deng, YX Fu Nature reviews Clinical oncology 14 (6), 365-379, 2017 | 945 | 2017 |
| Commensal bacteria protect against food allergen sensitization AT Stefka, T Feehley, P Tripathi, J Qiu, K McCoy, SK Mazmanian, ... Proceedings of the National Academy of Sciences 111 (36), 13145-13150, 2014 | 917 | 2014 |
| The efficacy of radiotherapy relies upon induction of type I interferon–dependent innate and adaptive immunity BC Burnette, H Liang, Y Lee, L Chlewicki, NN Khodarev, ... Cancer research 71 (7), 2488-2496, 2011 | 883 | 2011 |
| The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells J Qiu, JJ Heller, X Guo, EC Zong-ming, K Fish, YX Fu, L Zhou Immunity 36 (1), 92-104, 2012 | 875 | 2012 |
| Development and maturation of secondary lymphoid tissues YX Fu, DD Chaplin Annual review of immunology 17 (1), 399-433, 1999 | 815 | 1999 |
| A STING-activating nanovaccine for cancer immunotherapy M Luo, H Wang, Z Wang, H Cai, Z Lu, Y Li, M Du, G Huang, C Wang, ... Nature nanotechnology 12 (7), 648-654, 2017 | 785 | 2017 |
| CD47 blockade triggers T cell–mediated destruction of immunogenic tumors X Liu, Y Pu, K Cron, L Deng, J Kline, WA Frazier, H Xu, H Peng, YX Fu, ... Nature medicine 21 (10), 1209-1215, 2015 | 744 | 2015 |
| Phagocytosis checkpoints as new targets for cancer immunotherapy M Feng, W Jiang, BYS Kim, CC Zhang, YX Fu, IL Weissman Nature Reviews Cancer 19 (10), 568-586, 2019 | 705 | 2019 |
| Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B D Xu, J Fu, L Jin, H Zhang, C Zhou, Z Zou, JM Zhao, B Zhang, M Shi, ... The Journal of Immunology 177 (1), 739-747, 2006 | 654 | 2006 |
| The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity SG Park, Z Jiang, ED Mortenson, L Deng, O Radkevich-Brown, X Yang, ... Cancer cell 18 (2), 160-170, 2010 | 613 | 2010 |
| Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors P Yu, Y Lee, W Liu, T Krausz, A Chong, H Schreiber, YX Fu The Journal of experimental medicine 201 (5), 779-791, 2005 | 609 | 2005 |
| PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression H Tang, Y Liang, RA Anders, JM Taube, X Qiu, A Mulgaonkar, X Liu, ... The Journal of clinical investigation 128 (2), 580-588, 2018 | 502 | 2018 |
| Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade H Tang, Y Wang, LK Chlewicki, Y Zhang, J Guo, W Liang, J Wang, ... Cancer cell 29 (3), 285-296, 2016 | 469 | 2016 |
| Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy K Lu, C He, N Guo, C Chan, K Ni, G Lan, H Tang, C Pelizzari, YX Fu, ... Nature biomedical engineering 2 (8), 600-610, 2018 | 467 | 2018 |
| CD95 promotes tumour growth L Chen, SM Park, AV Tumanov, A Hau, K Sawada, C Feig, JR Turner, ... Nature 465 (7297), 492-496, 2010 | 466 | 2010 |
| Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora J Qiu, X Guo, EC Zong-ming, L He, GF Sonnenberg, D Artis, YX Fu, ... Immunity 39 (2), 386-399, 2013 | 457 | 2013 |
ralph weichselbaumprofessor radiation oncology university of chicagoVerified email at radonc.uchicago.edu
